Acro Biomedical (ACBM) Current Deferred Revenue (2017 - 2025)
Acro Biomedical's quarterly Current Deferred Revenue came in at $20000.0 in Q4 2025, little changed year-on-year from $20000.0 in Q4 2024, and little changed quarter-over-quarter from $20000.0 in Q3 2025.
Acro Biomedical has reported Current Deferred Revenue for 9 years, with the latest figure at $20000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue changed 0.0% year-over-year to $20000.0; the trailing twelve-month figure through Dec 2025 stood at $20000.0 (changed 0.0% YoY), and the FY2025 full-year result was $20000.0, changed 0.0% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $20000.0, roughly flat from $20000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $20000.0 in Q1 2021, with the low at $20000.0 in Q1 2021.
- Average Current Deferred Revenue over 5 years is $20000.0, with a median of $20000.0 recorded in 2021.
- Peak annual rise in Current Deferred Revenue reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Tracing ACBM's Current Deferred Revenue over 5 years: stood at $20000.0 in 2021, then changed by 0.0% to $20000.0 in 2022, then changed by 0.0% to $20000.0 in 2023, then changed by 0.0% to $20000.0 in 2024, then changed by 0.0% to $20000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $20000.0 (Q4 2025), $20000.0 (Q3 2025), and $20000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 20,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 20,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 20,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 30, 2020 | 20,000.00 |
| Sep 30, 2020 | 20,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 37,464.00 |
| Sep 30, 2019 | 116,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 20,000.00 |
| Mar 31, 2018 | 64,818.00 |
| Dec 31, 2017 | 64,981.00 |